132 related articles for article (PubMed ID: 16998874)
1. A rapid, three-step process for the preformulation of a recombinant ricin toxin A-chain vaccine.
Peek LJ; Brey RN; Middaugh CR
J Pharm Sci; 2007 Jan; 96(1):44-60. PubMed ID: 16998874
[TBL] [Abstract][Full Text] [Related]
2. Preformulation characterization of an aluminum salt-adjuvanted trivalent recombinant protein-based vaccine candidate against Streptococcus pneumoniae.
Iyer V; Hu L; Liyanage MR; Esfandiary R; Reinisch C; Meinke A; Maisonneuve J; Volkin DB; Joshi SB; Middaugh CR
J Pharm Sci; 2012 Sep; 101(9):3078-90. PubMed ID: 22538529
[TBL] [Abstract][Full Text] [Related]
3. Formulation development of a plant-derived H1N1 influenza vaccine containing purified recombinant hemagglutinin antigen.
Iyer V; Liyanage MR; Shoji Y; Chichester JA; Jones RM; Yusibov V; Joshi SB; Middaugh CR
Hum Vaccin Immunother; 2012 Apr; 8(4):453-64. PubMed ID: 22370514
[TBL] [Abstract][Full Text] [Related]
4. Improved formulation of a recombinant ricin A-chain vaccine increases its stability and effective antigenicity.
Carra JH; Wannemacher RW; Tammariello RF; Lindsey CY; Dinterman RE; Schokman RD; Smith LA
Vaccine; 2007 May; 25(21):4149-58. PubMed ID: 17408819
[TBL] [Abstract][Full Text] [Related]
5. Stabilization of a recombinant ricin toxin A subunit vaccine through lyophilization.
Hassett KJ; Cousins MC; Rabia LA; Chadwick CM; O'Hara JM; Nandi P; Brey RN; Mantis NJ; Carpenter JF; Randolph TW
Eur J Pharm Biopharm; 2013 Oct; 85(2):279-86. PubMed ID: 23583494
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Propylene Glycol-Mitigated Freeze/Thaw Agglomeration of a Frozen Liquid nOMV Vaccine Formulation by Static Light Scattering and Micro-Flow Imaging.
Mensch CD; Davis HB; Blue JT
PDA J Pharm Sci Technol; 2015; 69(4):477-98. PubMed ID: 26242785
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of aggregation of aluminum hydroxide adjuvant during freezing and drying.
Clausi AL; Merkley SA; Carpenter JF; Randolph TW
J Pharm Sci; 2008 Jun; 97(6):2049-61. PubMed ID: 17879291
[TBL] [Abstract][Full Text] [Related]
8. The structure, stability, and complex behavior of recombinant human gelatins.
Thyagarajapuram N; Olsen D; Middaugh CR
J Pharm Sci; 2007 Dec; 96(12):3363-78. PubMed ID: 17518362
[TBL] [Abstract][Full Text] [Related]
9. Effects of stabilizers on the destabilization of proteins upon adsorption to aluminum salt adjuvants.
Peek LJ; Martin TT; Elk Nation C; Pegram SA; Middaugh CR
J Pharm Sci; 2007 Mar; 96(3):547-57. PubMed ID: 17080408
[TBL] [Abstract][Full Text] [Related]
10. Stabilization of tetanus toxoid formulation containing aluminium hydroxide adjuvant against agitation.
Solanki VA; Jain NK; Roy I
Int J Pharm; 2012 Feb; 423(2):297-302. PubMed ID: 22155287
[TBL] [Abstract][Full Text] [Related]
11. Effects of solution conditions and surface chemistry on the adsorption of three recombinant botulinum neurotoxin antigens to aluminum salt adjuvants.
Vessely C; Estey T; Randolph TW; Henderson I; Nayar R; Carpenter JF
J Pharm Sci; 2007 Sep; 96(9):2375-89. PubMed ID: 17518359
[TBL] [Abstract][Full Text] [Related]
12. Improved stability of a protein vaccine through elimination of a partially unfolded state.
McHugh CA; Tammariello RF; Millard CB; Carra JH
Protein Sci; 2004 Oct; 13(10):2736-43. PubMed ID: 15340172
[TBL] [Abstract][Full Text] [Related]
13. Spectroscopic characterization of antibodies adsorbed to aluminium adjuvants: correlation with antibody vaccine immunogenicity.
Capelle MA; Brügger P; Arvinte T
Vaccine; 2005 Feb; 23(14):1686-94. PubMed ID: 15705473
[TBL] [Abstract][Full Text] [Related]
14. Effect of Aluminum Adjuvant and Preservatives on Structural Integrity and Physicochemical Stability Profiles of Three Recombinant Subunit Rotavirus Vaccine Antigens.
Agarwal S; Hickey JM; McAdams D; White JA; Sitrin R; Khandke L; Cryz S; Joshi SB; Volkin DB
J Pharm Sci; 2020 Jan; 109(1):476-487. PubMed ID: 31589875
[TBL] [Abstract][Full Text] [Related]
15. Stabilization of proteins by recombinant human gelatins.
Thyagarajapuram N; Olsen D; Middaugh CR
J Pharm Sci; 2007 Dec; 96(12):3304-15. PubMed ID: 17542020
[TBL] [Abstract][Full Text] [Related]
16. Physiochemical and functional characterization of antigen proteins eluted from aluminum hydroxide adjuvant.
Hutcheon CJ; Becker JO; Russell BA; Bariola PA; Peterson GJ; Stroop SD
Vaccine; 2006 Nov; 24(49-50):7214-25. PubMed ID: 16860908
[TBL] [Abstract][Full Text] [Related]
17. Finding a new vaccine in the ricin protein fold.
Olson MA; Carra JH; Roxas-Duncan V; Wannemacher RW; Smith LA; Millard CB
Protein Eng Des Sel; 2004 Apr; 17(4):391-7. PubMed ID: 15187223
[TBL] [Abstract][Full Text] [Related]
18. Quantitative Analysis of Vaccine Antigen Adsorption to Aluminum Adjuvant Using an Automated High-Throughput Method.
Ahl PL; Wang SC; Chintala R; Mensch C; Smith WJ; Wenger M; Blue J
PDA J Pharm Sci Technol; 2018; 72(2):149-162. PubMed ID: 29343619
[TBL] [Abstract][Full Text] [Related]
19. Application of extrinsic fluorescence spectroscopy for the high throughput formulation screening of aluminum-adjuvanted vaccines.
Ausar SF; Chan J; Hoque W; James O; Jayasundara K; Harper K
J Pharm Sci; 2011 Feb; 100(2):431-40. PubMed ID: 20740682
[TBL] [Abstract][Full Text] [Related]
20. Freeze-thaw stress of Alhydrogel ® alone is sufficient to reduce the immunogenicity of a recombinant hepatitis B vaccine containing native antigen.
Clapp T; Munks MW; Trivedi R; Kompella UB; Braun LJ
Vaccine; 2014 Jun; 32(30):3765-71. PubMed ID: 24856785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
